...（ALT）是正常的，故ALT的升高不能区分NAFLD及正常的肝脏，亦不能区分NAFLD及酒精性脂肪性肝病（alcoholic fatty liver disease，AFLD）。研究显示，正常的ALT值不能排除NASH及肝纤维化。
基于2个网页-相关网页
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的：观察疏肝降浊汤治疗非酒精性脂肪性肝病的临床疗效及安全性。
Objective: To observe the clinical effect and safety of Shugan Jiangzhuo Decoction in treating nonalcoholic fatty liver disease (NAFLD).
非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病、2型糖尿病及代 谢综合征临床症候群的关系密切，本文就非酒精性脂肪肝与代谢综合征的关系作一综述。
NAFLD is associated with atherosclerotic cardiovascular disease, type 2 diabetes and the clinical components of MS. We review the relationship between MS and NAFLD in this article.
应用推荐